Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - TripCo Outstanding Awards (Details)

v3.20.2
Stock-Based Compensation - TripCo Outstanding Awards (Details)
$ / shares in Units, shares in Thousands, $ in Millions
3 Months Ended 6 Months Ended
May 27, 2020
May 26, 2020
Jun. 30, 2020
USD ($)
$ / shares
shares
Jun. 30, 2020
USD ($)
item
$ / shares
shares
2019 Plan        
Additional disclosures        
Unvested value not yet recognized | $     $ 358 $ 358
Weighted average period the unrecognized compensation cost will be recognized       2 years
Amount of share reserve     2,300 2,300
Stock Options | Series A | 2019 Plan        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]        
Outstanding beginning balance       717
Granted       21
Cancelled or expired       (271)
Outstanding ending balance     467 467
Options exercisable     294 294
WAEP        
Weighted average exercise price, options outstanding (in dollars per share) | $ / shares       $ 13.65
Weighted average exercise price, options granted (in dollars per share) | $ / shares       2.11
Weighted average exercise price, options forfeited/cancelled (in dollars per share) | $ / shares       14.11
Weighted average exercise price, options outstanding (in dollars per share) | $ / shares     $ 12.86 12.86
Weighted average exercise price, options exercisable (in dollars per share) | $ / shares     $ 16.55 $ 16.55
Weighted average remaining contractual term outstanding       4 years 9 months 18 days
Weighted average remaining contractual term exercisable       3 years 10 months 24 days
Stock Options | Series B | 2019 Plan        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]        
Outstanding beginning balance       1,824
Outstanding ending balance     1,824 1,824
Options exercisable     1,824 1,824
WAEP        
Weighted average exercise price, options outstanding (in dollars per share) | $ / shares       $ 27.63
Weighted average exercise price, options outstanding (in dollars per share) | $ / shares     $ 27.63 27.63
Weighted average exercise price, options exercisable (in dollars per share) | $ / shares     $ 27.63 $ 27.63
Weighted average remaining contractual term outstanding       4 years 6 months
Weighted average remaining contractual term exercisable       4 years 6 months
Outstanding, aggregate intrinsic value | $     $ 31 $ 31
Exercisable, aggregate intrinsic value | $     31 $ 31
Restricted Stock Units (RSUs)        
Additional disclosures        
Vesting period 2 years 4 years    
Accelerated vesting additional share based compensation expense | $     $ 10  
Restricted Stock Units (RSUs) | Series B | 2019 Plan | CEO        
Additional disclosures        
RSUs granted       242
Weighted average grant date fair value, RSUs and MSUs granted (in dollars per share) | $ / shares       $ 3.08
Vesting period       1 year
Time Based RSUs | Series B | 2019 Plan | CEO        
Additional disclosures        
RSUs granted       30
Weighted average grant date fair value, RSUs and MSUs granted (in dollars per share) | $ / shares       $ 4.76
Percentage of base salary       50.00%
Number of quarters | item       3
Percentage of base salary to be waived       50.00%